Insuman Comb 25 Solostar (Insulin Human)

Insuman Comb 25 Solostar is a premixed human insulin used in the management of diabetes mellitus.

• Type 1 diabetes mellitus: provides basal and prandial insulin coverage to control blood glucose.
• Type 2 diabetes mellitus: assists in achieving glycemic targets when diet, exercise, and oral agents are insufficient.
• Gestational diabetes mellitus (when prescribed): offers rapid‑acting and intermediate‑acting insulin components for tight glucose control.

• Insulin Human binds to insulin receptors on muscle, adipose and hepatic cells, activating the receptor’s intrinsic tyrosine kinase activity. This triggers downstream signaling that promotes translocation of GLUT‑4 transporters, increasing glucose uptake, and suppresses hepatic gluconeogenesis, thereby lowering plasma glucose levels. The premixed formulation combines rapid‑acting and intermediate‑acting fractions to provide both mealtime and basal insulin effects.

Insuman Comb 25 Solostar may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects

• Hypoglycemia: symptoms such as sweating, tremor, or confusion due to low blood glucose.
• Injection site reactions: redness, swelling, or itching at the injection site.
• Weight gain: increase in body weight associated with insulin therapy.
• Lipodystrophy: localized changes in fat tissue at injection sites.

Serious or Rare Side Effects

• Allergic reaction: rash, urticaria, or anaphylaxis requiring immediate medical attention.
• Severe hypoglycemia with loss of consciousness or seizures.
• Insulin edema: rapid fluid retention leading to swelling, particularly in lower extremities.

When using Insuman Comb 25 Solostar, several precautions should be observed.

• Dose adjustment: modify dose based on blood glucose monitoring and clinical response.
• Hypoglycemia risk: educate patients on recognizing and treating low blood glucose promptly.
• Renal impairment: monitor kidney function and consider dose reduction in severe impairment.
• Concomitant medications: assess for drugs that may mask hypoglycemia symptoms.
• Pregnancy and lactation: use only if benefits outweigh potential risks and under medical supervision.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 25 Solostar can interact with other medicines, requiring attention to the level of interaction.

Major Interactions (Avoid)

• Beta‑blockers: may mask hypoglycemia symptoms and prolong insulin action.
• MAO‑A inhibitors: can potentiate insulin’s glucose‑lowering effect, increasing hypoglycemia risk.

Moderate Interactions (Monitor Closely)

• Oral hypoglycemic agents (e.g., sulfonylureas, meglitinides): additive glucose‑lowering effect; monitor for hypoglycemia.
• Corticosteroids: may raise blood glucose, requiring insulin dose adjustments.
• Thiazide diuretics: can impair glucose tolerance, necessitating closer monitoring.